Literature DB >> 19729063

Differential effects of TR ligands on hormone dissociation rates: evidence for multiple ligand entry/exit pathways.

Suzana T Cunha Lima1, Ngoc-Ha Nguyen, Marie Togashi, James W Apriletti, Phuong Nguyen, Igor Polikarpov, Thomas S Scanlan, John D Baxter, Paul Webb.   

Abstract

Some nuclear receptor (NR) ligands promote dissociation of radiolabeled bound hormone from the buried ligand binding cavity (LBC) more rapidly than excess unlabeled hormone itself. This result was interpreted to mean that challenger ligands bind allosteric sites on the LBD to induce hormone dissociation, and recent findings indicate that ligands bind weakly to multiple sites on the LBD surface. Here, we show that a large fraction of thyroid hormone receptor (TR) ligands promote rapid dissociation (T(1/2)<2h) of radiolabeled T(3) vs. T(3) (T(1/2) approximately 5-7h). We cannot discern relationships between this effect and ligand size, activity or affinity for TRbeta. One ligand, GC-24, binds the TR LBC and (weakly) to the TRbeta-LBD surface that mediates dimer/heterodimer interaction, but we cannot link this interaction to rapid T(3) dissociation. Instead, several lines of evidence suggest that the challenger ligand must interact with the buried LBC to promote rapid T(3) release. Since previous molecular dynamics simulations suggest that TR ligands leave the LBC by several routes, we propose that a subset of challenger ligands binds and stabilizes a partially unfolded intermediate state of TR that arises during T(3) release and that this effect enhances hormone dissociation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19729063      PMCID: PMC2784034          DOI: 10.1016/j.jsbmb.2009.08.003

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  28 in total

1.  Hormone selectivity in thyroid hormone receptors.

Authors:  R L Wagner; B R Huber; A K Shiau; A Kelly; S T Cunha Lima; T S Scanlan; J W Apriletti; J D Baxter; B L West; R J Fletterick
Journal:  Mol Endocrinol       Date:  2001-03

2.  Definition of the surface in the thyroid hormone receptor ligand binding domain for association as homodimers and heterodimers with retinoid X receptor.

Authors:  R C Ribeiro; W Feng; R L Wagner; C H Costa; A C Pereira; J W Apriletti; R J Fletterick; J D Baxter
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

Review 3.  Physiological and molecular basis of thyroid hormone action.

Authors:  P M Yen
Journal:  Physiol Rev       Date:  2001-07       Impact factor: 37.312

Review 4.  Design of thyroid hormone receptor antagonists from first principles.

Authors:  Paul Webb; Ngoc-Ha Nguyen; Grazia Chiellini; Hikari A I Yoshihara; Suzana T Cunha Lima; James W Apriletti; Ralff C J Ribeiro; Adhirai Marimuthu; Brian L West; Patrick Goede; Karin Mellstrom; Stefan Nilsson; Peter J Kushner; Robert J Fletterick; Thomas S Scanlan; John D Baxter
Journal:  J Steroid Biochem Mol Biol       Date:  2002-12       Impact factor: 4.292

5.  Ligand selectivity by seeking hydrophobicity in thyroid hormone receptor.

Authors:  Sabine Borngraeber; Mary-Jane Budny; Grazia Chiellini; Suzana T Cunha-Lima; Marie Togashi; Paul Webb; John D Baxter; Thomas S Scanlan; Robert J Fletterick
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

6.  Two resistance to thyroid hormone mutants with impaired hormone binding.

Authors:  B Russell Huber; Ben Sandler; Brian L West; Suzana T Cunha Lima; Hoa T Nguyen; James W Apriletti; John D Baxter; Robert J Fletterick
Journal:  Mol Endocrinol       Date:  2003-01-16

7.  Rational design and synthesis of a novel thyroid hormone antagonist that blocks coactivator recruitment.

Authors:  Ngoc-Ha Nguyen; James W Apriletti; Suzana T Cunha Lima; Paul Webb; John D Baxter; Thomas S Scanlan
Journal:  J Med Chem       Date:  2002-07-18       Impact factor: 7.446

8.  Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.

Authors:  A C Gee; K E Carlson; P G Martini; B S Katzenellenbogen; J A Katzenellenbogen
Journal:  Mol Endocrinol       Date:  1999-11

9.  Thyroid hormone receptor-beta mutations conferring hormone resistance and reduced corepressor release exhibit decreased stability in the N-terminal ligand-binding domain.

Authors:  B Russell Huber; Marion Desclozeaux; Brian L West; Suzana T Cunha-Lima; Hoa T Nguyen; John D Baxter; Holly A Ingraham; Robert J Fletterick
Journal:  Mol Endocrinol       Date:  2003-01

Review 10.  Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes.

Authors:  John D Baxter; Paul Webb
Journal:  Nat Rev Drug Discov       Date:  2009-04       Impact factor: 84.694

View more
  2 in total

1.  Site-specific basicities regulate molecular recognition in receptor binding: in silico docking of thyroid hormones.

Authors:  Gergő Tóth; Ferenc Baska; András Schretner; Akos Rácz; Béla Noszál
Journal:  Eur Biophys J       Date:  2013-08-02       Impact factor: 1.733

2.  Identification of a new hormone-binding site on the surface of thyroid hormone receptor.

Authors:  P C T Souza; A C Puhl; L Martínez; R Aparício; A S Nascimento; A C M Figueira; P Nguyen; P Webb; M S Skaf; I Polikarpov
Journal:  Mol Endocrinol       Date:  2014-02-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.